Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Combined invagination and duct-to-mucosa techniques with modifications: a new method of pancreaticojejunal anastomosis.

Zhu B, Geng L, Ma YG, Zhang YJ, Wu MC.

Hepatobiliary Pancreat Dis Int. 2011 Aug;10(4):422-7.

2.

Moving towards the New International Study Group for Pancreatic Surgery (ISGPS) definitions in pancreaticoduodenectomy: a comparison between the old and new.

Tan WJ, Kow AW, Liau KH.

HPB (Oxford). 2011 Aug;13(8):566-72. doi: 10.1111/j.1477-2574.2011.00336.x. Epub 2011 Jun 22.

3.

Neuroendocrine pancreatic tumors are risk factors for pancreatic fistula after pancreatic surgery.

Fendrich V, Merz MK, Waldmann J, Langer P, Heverhagen AE, Dietzel K, Bartsch DK.

Dig Surg. 2011;28(4):263-9. doi: 10.1159/000328667. Epub 2011 Jun 29.

PMID:
21720164
4.

Postoperative pancreatic fistula.

Hackert T, Werner J, Büchler MW.

Surgeon. 2011 Aug;9(4):211-7. doi: 10.1016/j.surge.2010.10.011. Epub 2010 Dec 13. Review.

PMID:
21672661
5.

Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors.

Kulke MH, Bendell J, Kvols L, Picus J, Pommier R, Yao J.

J Hematol Oncol. 2011 Jun 14;4:29. doi: 10.1186/1756-8722-4-29. Review.

6.

Prognostic factors and survival in patients with neuroendocrine tumors of the pancreas.

Wang DS, Zhang DS, Qiu MZ, Wang ZQ, Luo HY, Wang FH, Li YH, Xu RH.

Tumour Biol. 2011 Aug;32(4):697-705. doi: 10.1007/s13277-011-0170-9. Epub 2011 Apr 9.

PMID:
21479734
7.

Pancreatic neuroendocrine tumors.

Batcher E, Madaj P, Gianoukakis AG.

Endocr Res. 2011;36(1):35-43. doi: 10.3109/07435800.2010.525085. Review.

PMID:
21226566
8.
9.

Recent standardization of treatment strategy for pancreatic neuroendocrine tumors.

Imamura M.

World J Gastroenterol. 2010 Sep 28;16(36):4519-25.

10.

One hundred thirty resections for pancreatic neuroendocrine tumor: evaluating the impact of minimally invasive and parenchyma-sparing techniques.

DiNorcia J, Lee MK, Reavey PL, Genkinger JM, Lee JA, Schrope BA, Chabot JA, Allendorf JD.

J Gastrointest Surg. 2010 Oct;14(10):1536-46. doi: 10.1007/s11605-010-1319-3. Epub 2010 Sep 8.

PMID:
20824378
11.

Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients.

Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P, Niccoli P, Ménégaux F, Chabrier G, Borson-Chazot F, Tabarin A, Bouchard P, Delemer B, Beckers A, Bonithon-Kopp C.

World J Surg. 2010 Feb;34(2):249-55. doi: 10.1007/s00268-009-0290-1.

PMID:
19949948
12.

Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate?

Pitt SC, Pitt HA, Baker MS, Christians K, Touzios JG, Kiely JM, Weber SM, Wilson SD, Howard TJ, Talamonti MS, Rikkers LF.

J Gastrointest Surg. 2009 Sep;13(9):1692-8. doi: 10.1007/s11605-009-0946-z. Epub 2009 Jun 23.

13.

Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial.

Berger AC, Howard TJ, Kennedy EP, Sauter PK, Bower-Cherry M, Dutkevitch S, Hyslop T, Schmidt CM, Rosato EL, Lavu H, Nakeeb A, Pitt HA, Lillemoe KD, Yeo CJ.

J Am Coll Surg. 2009 May;208(5):738-47; discussion 747-9. doi: 10.1016/j.jamcollsurg.2008.12.031.

PMID:
19476827
14.

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.

Halfdanarson TR, Rabe KG, Rubin J, Petersen GM.

Ann Oncol. 2008 Oct;19(10):1727-33. doi: 10.1093/annonc/mdn351. Epub 2008 May 30.

15.

Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: Review of 125 patients.

Phan GQ, Yeo CJ, Hruban RH, Littemoe KD, Pitt HA, Cameron JL.

J Gastrointest Surg. 1998 Sep-Oct;2(5):473-82. doi: 10.1016/S1091-255X(98)80039-5.

PMID:
18335273
16.

Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs).

Blansfield JA, Choyke L, Morita SY, Choyke PL, Pingpank JF, Alexander HR, Seidel G, Shutack Y, Yuldasheva N, Eugeni M, Bartlett DL, Glenn GM, Middelton L, Linehan WM, Libutti SK.

Surgery. 2007 Dec;142(6):814-8; discussion 818.e1-2. Erratum in: Surgery. 2008 Feb;143(2):302.

PMID:
18063061
17.

Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution.

House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M, Gonen M, Olson SH, Kurtz RC, Brennan MF, Allen PJ.

J Gastrointest Surg. 2008 Feb;12(2):270-8. Epub 2007 Dec 1.

PMID:
18060467
18.

Endocrine precursor lesions of gastroenteropancreatic neuroendocrine tumors.

Klöppel G, Anlauf M, Perren A.

Endocr Pathol. 2007 Fall;18(3):150-5. Review.

PMID:
18058264
19.

Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands.

Vanounou T, Pratt WB, Callery MP, Vollmer CM Jr.

J Am Coll Surg. 2007 Oct;205(4):546-57. Epub 2007 Aug 23.

PMID:
17903728
20.

ADENOMA OF ISLET CELLS WITH HYPERINSULINISM: A REVIEW.

Whipple AO, Frantz VK.

Ann Surg. 1935 Jun;101(6):1299-335. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk